903550-26-5
C14H23BN2O3
278.16
1.16±0.1
74-78
white to off-white
Anticancer
Darolutamide
androgen receptor
Availability: | |
---|---|
DESCRIPTION
Darolutamide, a potent androgen receptor inhibitor, has shown remarkable efficacy in the treatment of non-metastatic castration-resistant prostate cancer. Our high-quality intermediates ensure a seamless production process, enabling a steady and reliable supply of this life-changing medication. Partner with us to bring this innovative treatment to patients, making a significant impact on prostate cancer care worldwide. Embrace the opportunity to revolutionize the field of prostate cancer treatment with Darolutamide.
content is empty!